Skip to main content
Log in

ASO Visual Abstract: Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases—Long-Term Follow-Up of Over 500 Patients

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sean P. Cleary MD.

Ethics declarations

Disclosure

T.R.H.: Consulting/advisory board for Ipsen, TerSera, ScioScientific, Curium, Advanced Accelerator Applications (a Novartis company), Terumo, ITM Isotopen Technologien Muenchen, and Crinetics, as well as research support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Basilea, Turnstone Biologics, and Agios. The remaining authors have no relevant financial disclosures and declare no conflicts of interest. Financial support was provided internally by the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery and the Mayo Clinic Department of Surgery.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gudmundsdottir, H., Habermann, E.B., Vierkant, R.A. et al. ASO Visual Abstract: Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases—Long-Term Follow-Up of Over 500 Patients. Ann Surg Oncol 30, 4854–4855 (2023). https://doi.org/10.1245/s10434-023-13424-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13424-4

Navigation